Global Cancer Immunotherapies Market 2016-2020

SKU ID : TNV- 10278829

Publishing Date : 27-Apr-2016

No. of pages : 121

PRICE
2500
4000


  • About Cancer Immunotherapies

    Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.

    Technavio’s analysts forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.
    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Amgen
    • Bristol-Myers Squibb
    • F. Hoffmann-La Roche
    • GlaxoSmithKline
    • Merck
    • Takeda Pharmaceuticals

    Other prominent vendors
    • AbbVie
    • ADC Therapeutics
    • Agensys
    • Astellas
    • AstraZeneca
    • Bayer
    • Biogen
    • Biotech Pharmaceutical
    • Boehringer-Ingelheim
    • Celgene
    • Celldex Therapeutics
    • Chugai Pharmaceutical
    • CTI Biopharma
    • Daiichi Sankyo
    • Eli Lilly
    • Fortress Biotech
    • Genmab
    • Immunomedics
    • Intas Pharmaceuticals
    • Janssen Biotech
    • Kyowa Hakko Kirin
    • MedImmune
    • Morphotek
    • Neovii Biotech
    • Novartis
    • OncoMed Pharmaceuticals
    • Pfizer
    • Sanofi
    • Seattle Genetics
    • Spectrum Pharmaceuticals
    • TG Therapeutics
    • XBiotech

    Market driver
    • Increase in demand for cancer monoclonal antibodies
    • For a full, detailed list, view our report

    Market challenge
    • Patent expiry of top-selling drugs
    • For a full, detailed list, view our report

    Market trend
    • Emergence of targeted and combination therapies
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports